X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1260) 1260
Publication (154) 154
Book Chapter (22) 22
Conference Proceeding (10) 10
Book Review (8) 8
Dissertation (4) 4
Web Resource (3) 3
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (730) 730
oncology (426) 426
index medicus (425) 425
male (395) 395
female (392) 392
adult (317) 317
chromosome 1p (304) 304
brain neoplasms - genetics (299) 299
clinical neurology (298) 298
middle aged (289) 289
prognosis (250) 250
tumors (237) 237
oligodendroglioma (235) 235
aged (232) 232
gliomas (225) 225
chromosomes, human, pair 1 - genetics (224) 224
pathology (223) 223
oligodendroglioma - genetics (183) 183
chromosome deletion (177) 177
brain neoplasms - pathology (176) 176
survival (174) 174
mutation (173) 173
glioma (172) 172
chromosomes, human, pair 1 (164) 164
1p/19q (153) 153
loss of heterozygosity (144) 144
neurosciences (140) 140
cancer (137) 137
medicine & public health (136) 136
neuroblastoma (136) 136
adolescent (135) 135
19q (133) 133
glioblastoma (132) 132
in situ hybridization, fluorescence (131) 131
glioma - genetics (130) 130
child (123) 123
classification (120) 120
expression (120) 120
chromosomes, human, pair 19 - genetics (118) 118
genetics & heredity (116) 116
chemotherapy (115) 115
oligodendroglioma - pathology (109) 109
analysis (107) 107
temozolomide (103) 103
diagnosis (101) 101
comparative genomic hybridization (98) 98
neuroblastoma - genetics (98) 98
brain neoplasms - diagnosis (95) 95
young adult (94) 94
isocitrate dehydrogenase - genetics (92) 92
child, preschool (89) 89
chromosome aberrations (81) 81
genetic aspects (80) 80
infant (80) 80
retrospective studies (79) 79
immunohistochemistry (78) 78
oligodendroglial tumors (77) 77
1p/19q codeletion (76) 76
glioma - pathology (76) 76
neurology (75) 75
phase-iii trial (74) 74
1p/19q loss (73) 73
chromosomes, human, pair 19 (73) 73
deletion (72) 72
surgery (72) 72
anaplastic oligodendroglioma (71) 71
heterozygosity (69) 69
astrocytoma (68) 68
mutations (68) 68
physics, nuclear (68) 68
brain cancer (67) 67
idh1 (67) 67
aged, 80 and over (66) 66
anaplastic oligodendrogliomas (66) 66
1p shell (64) 64
brain tumors (64) 64
idh (64) 64
mgmt (64) 64
in-situ hybridization (63) 63
research (63) 63
brain neoplasms - metabolism (62) 62
gene deletion (62) 62
neuroblastoma - pathology (61) 61
astrocytomas (60) 60
biomarkers, tumor - genetics (60) 60
gene amplification (60) 60
brain-tumors (59) 59
gene (59) 59
neoplasms (59) 59
cell biology (58) 58
survival analysis (58) 58
brain neoplasms - mortality (57) 57
dna methylation (57) 57
oligodendroglioma - diagnosis (55) 55
radiotherapy (55) 55
central-nervous-system (53) 53
polymerase chain reaction (51) 51
progression (51) 51
genetics (50) 50
magnetic resonance imaging (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1219) 1219
German (22) 22
Chinese (17) 17
French (17) 17
Spanish (9) 9
Japanese (4) 4
Czech (3) 3
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AJNR. American journal of neuroradiology, ISSN 0195-6108, 03/2019, Volume 40, Issue 3, pp. 426 - 432
BACKGROUND AND PURPOSE: Isocitrate dehydrogenase (IDH)-mutant lower grade gliomas are classified as oligodendrogliomas or diffuse astrocytomas based on... 
IDH1-MUTATION | 1P/19Q CODELETION | SPECTROSCOPY | SIGNATURES | OLIGODENDROGLIAL TUMORS | PERFUSION | MOLECULAR DIAGNOSTICS | NEUROIMAGING | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | CLINICAL NEUROLOGY | DELETION
Journal Article
MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY, ISSN 0035-8711, 02/2015, Volume 446, Issue 4, pp. 3669 - 3675
We measure the activity and orbital characteristics of the eta-Aquariid meteor shower appropriate to meteoroids of 200 mu m size (mass approximate to 5-10 mu... 
ASTRONOMY & ASTROPHYSICS | ORBIT-RADAR | STREAM | comets: individual: 1P/Halley | meteorites, meteors, meteoroids
Journal Article
Brain, ISSN 0006-8950, 10/2007, Volume 130, Issue 10, pp. 2596 - 2606
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 35, pp. 5874 - 5880
Purpose The standard of care for anaplastic gliomas is surgery followed by radiotherapy. The NOA-04 phase III trial compared efficacy and safety of... 
MALIGNANT GLIOMA | SURVIVAL | ONCOLOGY | GLIOBLASTOMA-MULTIFORME | EUROPEAN ORGANIZATION | MGMT GENE | OLIGODENDROGLIAL TUMORS | RADIOTHERAPY | CHEMOTHERAPY | BRAIN-TUMORS | 1P/19Q LOSS | Procarbazine - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lomustine - adverse effects | Middle Aged | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Glioma - radiotherapy | Glioma - genetics | Young Adult | DNA Methylation | Time Factors | Radiotherapy, Adjuvant - adverse effects | Glioma - pathology | Treatment Failure | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Vincristine - administration & dosage | Adult | Female | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Promoter Regions, Genetic | Dacarbazine - administration & dosage | Glioma - mortality | Drug Administration Schedule | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Brain Neoplasms - drug therapy | Disease Progression | Disease-Free Survival | DNA Modification Methylases - genetics | Procarbazine - adverse effects | Vincristine - adverse effects | Aged | Mutation | Antineoplastic Agents, Alkylating - adverse effects | Lomustine - administration & dosage | Glioma - drug therapy | Index Medicus
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 03/2018, Volume 45, Issue 3, pp. 443 - 451
PurposeThe molecular features isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion have gained major importance for both glioma typing and prognosis... 
IDH mutation | Glioma | 1p/19q co-deletion | FET pet | Tyrosine | Brain | Typing | Brain tumors | Brain cancer | Positron emission | Parameter sensitivity | Gene deletion | Clonal deletion | Classification | Tomography | Deletion | Diagnostic systems | Mutation | Isocitrate dehydrogenase | Positron emission tomography
Journal Article
Journal Article
NEURO-ONCOLOGY, ISSN 1522-8517, 02/2018, Volume 20, Issue 2, pp. 279 - 288
Stratification of glioma according to isocitrate dehydrogenase 1/2 (IDH1/2) mutation and 1p/19q codeletion status has gained major importance in the new World... 
19q co-deletion | F-18-FET-PET | 1P/19Q | IDH1 | kinetic analysis | RESPONSE ASSESSMENT | 2 mutation | CLASSIFICATION | TUMORS | CLINICAL NEUROLOGY | INTRATUMORAL HOMOGENEITY | prognostic value | NEUROONCOLOGY WORKING GROUP | ONCOLOGY | LOW-GRADE GLIOMA | glioma | CENTRAL-NERVOUS-SYSTEM | MUTATIONS | PET
Journal Article
Journal of Neurosurgery, ISSN 0022-3085, 10/2016, Volume 125, Issue 4, pp. 995 - 1001
OBJECTIVE 1p/19q co-deletion is a well-established tumor cell specific chromosomal abnormality in oligodendroglial tumors. The endothelial cells (ECs) of... 
Angiogenesis | Oncology | Prognosis | 1p/19q | Anaplastic oligodendroglioma | Endothelial cells | SURGERY | endothelial cells | BEVACIZUMAB | angiogenesis | PATHOLOGY | anaplastic oligodendroglioma | prognosis | oncology | CLINICAL NEUROLOGY | TEMOZOLOMIDE | TRIAL | GLIOBLASTOMA | RADIOTHERAPY
Journal Article
Journal Article